Entities / Person
Steve Cohen.
researcher (ORCID 0000-0002-9471-4586)
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
A new redistricting map has been implemented in Shelby County, carving it into new districts and eliminating the state's only Democratic representative.Some support2 reports
-
Steve Cohen recommended Genmab as a buy, and Truist Securities raised its price target for the company.Some support1 report
-
Steve Cohen recommended Zai Lab as a biotech stock, and Leerink partners raised the price target for Zai Lab on July 25, 2025.Some support1 report
-
Steve Cohen recommended BridgeBio as a top biotech stock on July 25, 2025.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around Steve Cohen this week
News at the entities that move Steve Cohen most-
Market OperationalTrump's pledge to unleash oil and gas is reported to benefit US stocks, involving Diamond Hill Investment Group.Moves Steve Cohen
Connections
The 3 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Point72 Asset Management Structural
Steve Cohen is formally associated with Point72 Asset Management by adopting its name.
-
Market Operational
Steve Cohen's cautious comments are observed to influence investor skittishness and the state of the market.
-
Tennessee Democratic Party Shared context
The single snapshot provides no evidence of a direct or meaningful relationship between the Tennessee Democratic Party and Steve Cohen.
History
Events by the month they beganJuly 2026
1 eventJune 2026
4 events- A new redistricting map has been implemented in Shelby County, carving it into new districts and eliminating the state's only Democratic representative.
- Steve Cohen recommended Genmab as a buy, and Truist Securities raised its price target for the company.
- Steve Cohen recommended Zai Lab as a biotech stock, and Leerink partners raised the price target for Zai Lab on July 25, 2025.
- Steve Cohen recommended BridgeBio as a top biotech stock on July 25, 2025.